Second Hospital of Anhui Medical University
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
2021 · Zhenggang Ren, Jianming Xu, et al. · The Lancet Oncology
Efficacy Comparison of 16 Interventions for Myopia Control in Children
2016 · Jinhai Huang, Daizong Wen, et al. · Ophthalmology
The establishment of reference sequence for SARS‐CoV‐2 and variation analysis
2020 · Changtai Wang, Zhongping Liu, et al. · Journal of Medical Virology